Vimta Labs Ltd

Vimta Labs Employee Stock Options

Vimta Labs allotted 12,955 ESOP shares under its 2021 plan. Paid-up capital rose to ₹8,93,99,718, raising dilution for shareholders.

Vimta Labs Credit Rating

CARE Ratings has reaffirmed the bank facility ratings of Vimta Labs Limited. The disclosure updates stakeholders on the company's ongoing credit facilities.

Vimta Labs Investor Presentation: Key Takeaways

Vimta Labs reported Q1 FY27 total income of INR 1,129 million, up 13.7% YoY. Strategy focuses on diversifying into Biologics (CRAD) and strengthening domestic food testing.

Call

Guides 25% growth

Vimta Labs Earnings Call: Key Takeaways

Vimta Labs reports 13.7% YoY revenue growth in Q1 FY27, driven by strong performance in Pharma and Food testing segments with a 36.4% EBITDA margin.

Vimta Labs Q1 FY27 Results: Net Profit ₹21 Cr, Up 11.1% YoY

Vimta Labs Ltd reported revenue from operations of ₹109.1 Cr (+11.8% YoY) and net profit of ₹21 Cr (+11.1% YoY) for Q1 FY27.

Key figure

Net profit ₹21 Cr · +11.1% YoY

Vimta Labs Earnings Call: Key Takeaways

Vimta Labs reported Q4 FY26 revenue of ₹1,120M (+16.6% YoY) and FY26 revenue of ₹4,163M (+19.5% YoY). Strategy focuses on core pharma/food testing and entry into biologics.

Vimta Labs Earnings Call: Key Takeaways

Vimta Labs reported Q4 FY26 revenue of ₹1,120 Mn and PAT of ₹211 Mn with strong margins across TIC segments.

Vimta Labs Earnings Call: Key Takeaways

Vimta Labs reported strong FY26 performance with Total Income reaching ₹4,163 Mn, up 19.5% YoY, and PAT at ₹775 Mn. Strategy focuses on expanding TIC services across Pharma, Food, and Electronics sectors.

Vimta Labs Q4 FY26 Results: Net Profit ₹21.1 Cr, Up 15.3% YoY

Vimta Labs Ltd reported revenue from operations of ₹109.2 Cr (+15.7% YoY) and net profit of ₹21.1 Cr (+15.3% YoY) for Q4 FY26.

Key figure

Net profit ₹21.1 Cr · +15.3% YoY